Edition:
United Kingdom

TRACON Pharmaceuticals Inc (TCON.OQ)

TCON.OQ on NASDAQ Stock Exchange Global Market

0.62USD
17 Jun 2019
Change (% chg)

$-0.01 (-2.38%)
Prev Close
$0.63
Open
$0.62
Day's High
$0.62
Day's Low
$0.62
Volume
856
Avg. Vol
67,565
52-wk High
$3.08
52-wk Low
$0.50

About

TRACON Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics for cancer, wet age-related macular degeneration (wet AMD) and fibrotic diseases. The Company's research focuses on antibodies that bind to the endoglin receptor, which is... (more)

Overall

Beta: 2.46
Market Cap(Mil.): $18.89
Shares Outstanding(Mil.): 29.94
Dividend: --
Yield (%): --

Financials

  TCON.OQ Industry Sector
P/E (TTM): -- 103.12 37.45
EPS (TTM): -1.13 -- --
ROI: -97.39 7.69 12.16
ROE: -118.02 8.19 16.93

Earnings vs. Estimates